← Eichor
Condition: Severe Asthma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Severe Asthma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Predictive Signature of Benralizumab Response
Phase 4 · 20 location(s) · Nantes University Hospital · NCT04565483Experience of Biologic Treatments for Severe Asthma: a Survey
Phase N/A · 1 location(s) · Royal Devon and Exeter NHS Foundation Trust · NCT06903780Remission in Adults With Severe Asthma in Thailand
Phase N/A · 1 location(s) · Thammasat University · NCT07328035Exploring the Lived Experience of Young Adults With Severe Asthma
Phase N/A · 1 location(s) · Manchester University NHS Foundation Trust · NCT06681545Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Se
NA · 1 location(s) · Poitiers University Hospital · NCT05691218Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
Phase 4 · 2 location(s) · University of Alberta · NCT06705764Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
Phase N/A · 2 location(s) · Qianfoshan Hospital · NCT07530770Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial
NA · 1 location(s) · Hospital Clinic of Barcelona · NCT06314477A Non-interventional, Prospective Study With Benralizumab
Phase N/A · 41 location(s) · AstraZeneca · NCT06422078A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Phase 3 · 34 location(s) · Generate Biomedicines · NCT07359846ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Phase 2 · 14 location(s) · Enveda Therapeutics · NCT07301255International Severe Asthma Registry_Hong Kong
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07524543Deployment o the Multidisciplinary Prospective Cohort Imminent
NA · 1 location(s) · University Hospital, Lille · NCT04334031Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Phase 3 · 1 location(s) · Shanghai Mabgeek Biotech.Co.Ltd · NCT06837922SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Tra
NA · 1 location(s) · University of Liege · NCT04395937Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY A
Phase 3 · 74 location(s) · Sanofi · NCT06191315Use of Biologics for Severe Asthma in Hong Kong
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT06778746A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · 58 location(s) · Kymera Therapeutics, Inc. · NCT07323654Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Phase 2 · 1 location(s) · Longbio Pharma · NCT07342803Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Phase 4 · 3 location(s) · University of California, San Diego · NCT06385236A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Phase 3 · 53 location(s) · Generate Biomedicines · NCT07276724Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
Phase N/A · 37 location(s) · AstraZeneca · NCT06472310Real Life Study of Biologicals in Patients With Severe CRSwNP
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05938972A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Phase 2 · 14 location(s) · Kinaset Therapeutics Inc · NCT07532265Execise Intervention in Adult Severe Asthma
NA · 1 location(s) · Helsinki University Central Hospital · NCT07655037The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment S
NA · 10 location(s) · Beijing Chao Yang Hospital · NCT07136025Expertise Asthma COPD Program with Digital Support
Phase 3 · 1 location(s) · Franciscus Gasthuis · NCT05831566Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NA · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT06015256Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
Phase 2 · 13 location(s) · Oneness Biotech Co., Ltd. · NCT05008965Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
Phase 3 · 76 location(s) · AstraZeneca · NCT07363642
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.